Retraction of ‘Berberine alleviates amyloid beta-induced injury in Alzheimer’s disease by miR-107/ZNF217’ by Jing Wang et al., RSC Adv., 2019, 9, 25232–25239, DOI: 10.1039/C9RA04500G.
L. Fisher, RSC Adv., 2021, 11, 5001 DOI: 10.1039/D1RA90031E
This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.
Read more about how to correctly acknowledge RSC content.
Please wait while we load your content...
